Skip Navigation
You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
U.S. Department of Health and Human Services
•
National Institutes of Health
Advanced Search
NIAID Home
Health & Research A to Z
Labs & Scientific Resources
Funding
About NIAID
News & Events
NIAID
>
Labs & Scientific Resources
>
Labs at NIAID
>
Info about NIAID Labs
>
Malaria Immunology and Vaccinology
Malaria Immunology and Vaccinology
Current Collaborations
Product Groups
Vaccine Development Pipeline
Patrick E. Duffy, M.D., Vaccine Development Unit, Laboratory of Malaria Immunology and Vaccinology, NIAID, NIH
Patrick E. Duffy, M.D., Pathogenesis and Immunity Section, Laboratory of Malaria Immunology and Vaccinology, NIAID, NIH
Michal Fried, Ph.D., Molecular Pathogenesis and Biomarkers Section, Laboratory of Malaria Immunology and Vaccinology, NIAID, NIH
Michael Walther, Ph.D., M.Sc., Human Immune Regulation Section, Laboratory of Malaria Immunology and Vaccinology, NIAID, NIH
Skip Website Tools
Website Tools
Email this page
Print this page
Get email updates
Order publications
Skip Stay Connected
Stay Connected
Additional Information From NIAID
DIR Overview
Postdoctoral Positions Available
Training Experience
Javascript Error
Your browser JavaScript is turned off causing certain features of the NIAID Institute of Allergy and Infectious Diseases web site to work incorrectly. Please visit your browser settings and turn JavaScript on.
Read more information on enabling JavaScript.
Laboratory of Malaria Immunology and Vaccinology
Skip Content Marketing
Share this:
Current Collaborations
Research Teams and Collaborators
Malaria Research and Training Center, Medical School,
University of Bamako, Mali, Africa
(French)
Clinical trials of malaria vaccines and studies of immunology and epidemiology in Mali
Armed Forces Research Institute of Medical Sciences
, Bangkok, Thailand
Determine transmission blocking activity against
P. falciparum
National Institute for Medical Research
, UK
Investigation of the role of surface antigens of the malaria parasite and the nature and regulation of the host response in pregnancy-associated malaria
The Jenner Institute
, Oxford University
Trial of a multi-component malaria vaccine for
P. falciparum
Statens Serum Institut
Adjuvants for enhancing immunogenicity and improving protective efficacy of malaria antigens
Walter Reed Army Institute of Research
Preclinical immunogenicity studies of liver stage candidate vaccines
Naval Medical Research Center
Identification of antigens for pre-erythrocytic vaccines
Infectious Diseases Research Institute
Adjuvants for enhancing immunogenicity and improving protective efficacy of malaria antigens
Johns Hopkins University Center for Immunization Research
Conduct clinical trials on malaria vaccines
Fraunhofer USA, Center for Molecular Biotechnology
Support for development of transmission blocking vaccines
Seattle Biomedical Research Institute
(in conjunction with the Bill & Melinda Gates Foundation)
Supporting research of pregnancy malaria
Merck Research Laboratories
Conjugation to enhance protein vaccine immunogenicity
Novartis
Conjugation to enhance protein vaccine immunogenicity
Sanaria
Studies of whole organism vaccines
NIAID Laboratory of Malaria and Vector Research
Studies of malaria transmission and malaria pathogenesis in Mali
NIAID Laboratory of Clinical Infectious Diseases
Epidemiological studies of severe malaria in Tanzania
Funders
PATH/Malaria Vaccine Initiative
Support of transmission blocking vaccine clinical
Bill & Melinda Gates Foundation
Studies of pregnancy malaria vaccines, identification of pre-erythrocytic antigens, and transmission blocking vaccine development
Last Updated March 05, 2012